Table of Contents Author Guidelines Submit a Manuscript
Mediators of Inflammation
Volume 2015, Article ID 329418, 10 pages
http://dx.doi.org/10.1155/2015/329418
Research Article

Anti-Inflammatory Properties of Low and High Doxycycline Doses: An In Vitro Study

Department of Clinical Medicine and Surgery, Section of Dermatology, University of Naples Federico II, Via S. Pansini 5, 80131 Naples, Italy

Received 13 January 2015; Accepted 25 March 2015

Academic Editor: Tânia Silvia Fröde

Copyright © 2015 Roberta Di Caprio et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. O. Griffin, E. Fricovsky, G. Ceballos, and F. Villarreal, “Tetracyclines: a pleitropic family of compounds with promising therapeutic properties. Review of the literature,” The American Journal of Physiology—Cell Physiology, vol. 299, no. 3, pp. C539–C548, 2010. View at Publisher · View at Google Scholar · View at Scopus
  2. G. E. Stein and T. Babinchak, “Tigecycline: an update,” Diagnostic Microbiology and Infectious Disease, vol. 75, no. 4, pp. 331–336, 2013. View at Publisher · View at Google Scholar · View at Scopus
  3. B. M. Duggar, “Aureomycin: a product of the continuing search for new antibiotics,” Annals of the New York Academy of Sciences, vol. 51, no. 2, pp. 177–181, 1948. View at Publisher · View at Google Scholar · View at Scopus
  4. P. A. Kramer, D. J. Chapron, J. Benson, and S. A. Mercik, “Tetracycline absorption in elderly patients with achlorhydria,” Clinical Pharmacology and Therapeutics, vol. 23, no. 4, pp. 467–472, 1978. View at Google Scholar · View at Scopus
  5. N. C. Klein and B. A. Cunha, “Tetracyclines,” Medical Clinics of North America, vol. 79, no. 4, pp. 789–801, 1995. View at Google Scholar · View at Scopus
  6. I. Chopra and M. Roberts, “Tetracycline antibiotics: mode of action, applications, molecular biology, and epidemiology of bacterial resistance,” Microbiology and Molecular Biology Reviews, vol. 65, no. 2, pp. 232–260, 2001. View at Publisher · View at Google Scholar · View at Scopus
  7. F. Bahrami, D. L. Morris, and M. H. Pourgholami, “Tetracyclines: drugs with huge therapeutic potential,” Mini-Reviews in Medicinal Chemistry, vol. 12, no. 1, pp. 44–52, 2012. View at Publisher · View at Google Scholar · View at Scopus
  8. A. N. Sapadin and R. Fleischmajer, “Tetracyclines: nonantibiotic properties and their clinical implications,” Journal of the American Academy of Dermatology, vol. 54, no. 2, pp. 258–265, 2006. View at Publisher · View at Google Scholar · View at Scopus
  9. G. Dormn, S. Cseh, I. Hajd et al., “Matrix metalloproteinase inhibitors: a critical appraisal of design principles and proposed therapeutic utility,” Drugs, vol. 70, no. 8, pp. 949–964, 2010. View at Publisher · View at Google Scholar · View at Scopus
  10. U. Meyer-Hoffert, “Reddish, scaly, and itchy: how proteases and their inhibitors contribute to inflammatory skin diseases,” Archivum Immunologiae et Therapiae Experimentalis, vol. 57, no. 5, pp. 345–354, 2009. View at Publisher · View at Google Scholar · View at Scopus
  11. J. J. Leyden, K. J. McGinley, and A. M. Kligman, “Tetracycline and minocycline treatment,” Archives of Dermatology, vol. 118, no. 1, pp. 19–22, 1982. View at Publisher · View at Google Scholar · View at Scopus
  12. J. J. Leyden, K. Kaidbey, and E. H. Gans, “The antimicrobial effects in vivo of minocycline, doxycycline and tetracycline in humans,” Journal of Dermatological Treatment, vol. 7, no. 4, pp. 223–225, 1996. View at Publisher · View at Google Scholar · View at Scopus
  13. C. Ishikawa, T. Tsuda, H. Konishi, N. Nakagawa, and K. Yamanishi, “Tetracyclines modulate protease-activated receptor 2-mediated proinflammatory reactions in epidermal keratinocytes,” Antimicrobial Agents and Chemotherapy, vol. 53, no. 5, pp. 1760–1765, 2009. View at Publisher · View at Google Scholar · View at Scopus
  14. H. Bachelez, P. Senet, J. Cadranel, A. Kaoukhov, and L. Dubertret, “The use of tetracyclines for the treatment of sarcoidosis,” Archives of Dermatology, vol. 137, no. 1, pp. 69–73, 2001. View at Google Scholar · View at Scopus
  15. H. C. Korting and C. Schöllmann, “Tetracycline actions relevant to rosacea treatment,” Skin Pharmacology and Physiology, vol. 22, no. 6, pp. 287–294, 2009. View at Publisher · View at Google Scholar · View at Scopus
  16. J. Q. Del Rosso, G. F. Webster, M. Jackson et al., “Two randomized phase III clinical trials evaluating anti-inflammatory dose doxycycline (40-mg doxycycline, USP capsules) administered once daily for treatment of rosacea,” Journal of the American Academy of Dermatology, vol. 56, no. 5, pp. 791–802, 2007. View at Publisher · View at Google Scholar · View at Scopus
  17. K. McKeage and E. D. Deeks, “Doxycycline 40 mg capsules (30 mg immediate-release/10 mg delayed-release beads): anti-inflammatory dose in rosacea,” American Journal of Clinical Dermatology, vol. 11, no. 3, pp. 217–222, 2010. View at Publisher · View at Google Scholar · View at Scopus
  18. K. J. Livak and T. D. Schmittgen, “Analysis of relative gene expression data using real-time quantitative PCR and the 2-ΔΔCT method,” Methods, vol. 25, no. 4, pp. 402–408, 2001. View at Publisher · View at Google Scholar · View at Scopus
  19. S. Lembo, A. Balato, R. di Caprio et al., “The modulatory effect of ellagic acid and rosmarinic acid on ultraviolet-B-induced cytokine/chemokine gene expression in skin keratinocyte (HaCaT) cells,” BioMed Research International, vol. 2014, Article ID 346793, 8 pages, 2014. View at Publisher · View at Google Scholar
  20. R. Skidmore, R. Kovach, C. Walker et al., “Effects of subantimicrobial-dose doxycycline in the treatment of moderate acne,” Archives of Dermatology, vol. 139, no. 4, pp. 459–464, 2003. View at Publisher · View at Google Scholar · View at Scopus
  21. L. M. Golub, H. M. Lee, M. E. Ryan, W. V. Giannobile, J. Payne, and T. Sorsa, “Tetracyclines inhibit connective tissue breakdown by multiple non-antimicrobial mechanisms,” Advances in Dental Research, vol. 12, no. 2, pp. 12–26, 1998. View at Publisher · View at Google Scholar · View at Scopus
  22. A. Eslami, C. L. Gallant-Behm, D. A. Hart et al., “Expression of integrin αvβ6 and TGF-β in Scarless vs Scar-forming wound healing,” Journal of Histochemistry & Cytochemistry, vol. 57, no. 6, pp. 543–557, 2009. View at Publisher · View at Google Scholar · View at Scopus
  23. S. Liu, M. Kapoor, C. P. Denton, D. J. Abraham, and A. Leask, “Loss of β1 integrin in mouse fibroblasts results in resistance to skin scleroderma in a mouse model,” Arthritis & Rheumatism, vol. 60, no. 9, pp. 2817–2821, 2009. View at Publisher · View at Google Scholar · View at Scopus
  24. R. Huggenberger and M. Detmar, “The cutaneous vascular system in chronic skin inflammation,” Journal of Investigative Dermatology Symposium Proceedings, vol. 15, no. 1, pp. 24–32, 2011. View at Publisher · View at Google Scholar · View at Scopus
  25. F. O. Nestle, P. Di Meglio, J.-Z. Qin, and B. J. Nickoloff, “Skin immune sentinels in health and disease,” Nature Reviews Immunology, vol. 9, no. 10, pp. 679–691, 2009. View at Publisher · View at Google Scholar · View at Scopus
  26. S. Pastore, F. Mascia, V. Mariani, and G. Girolomoni, “Keratinocytes in skin inflammation,” Expert Review of Dermatology, vol. 1, pp. 279–291, 2006. View at Google Scholar
  27. T. Yoshimura, K. Matsushima, S. Tanaka et al., “Purification of a human monocyte-derived neutrophil chemotactic factor that has peptide sequence similarity to other host defense cytokines,” Proceedings of the National Academy of Sciences of the United States of America, vol. 84, no. 24, pp. 9233–9237, 1987. View at Publisher · View at Google Scholar · View at Scopus
  28. N. Allon, S. Chapman, Y. Shalem, R. Brandeis, B. A. Weissman, and A. Amir, “Lipopolysaccharide induced protection against sulfur mustard cytotoxicity in RAW264.7 cells through generation of TNF-α,” Journal of Toxicological Sciences, vol. 35, no. 3, pp. 345–355, 2010. View at Publisher · View at Google Scholar · View at Scopus
  29. R. Gapski, H. Hasturk, T. E. van Dyke et al., “Systemic MMP inhibition for periodontal wound repair: results of a multi-centre randomized-controlled clinical trial,” Journal of Clinical Periodontology, vol. 36, no. 2, pp. 149–156, 2009. View at Publisher · View at Google Scholar · View at Scopus
  30. R. A. Ashley, “Clinical trials of a matrix metalloproteinase inhibitor in human periodontal disease. SDD Clinical Research Team,” Annals of the New York Academy of Sciences, vol. 878, pp. 335–346, 1999. View at Publisher · View at Google Scholar · View at Scopus
  31. J. G. Caton, S. G. Ciancio, T. M. Blieden et al., “Treatment with subantimicrobial dose doxycycline improves the efficacy of scaling and root planing in patients with adult periodontitis,” Journal of Periodontology, vol. 71, no. 4, pp. 521–532, 2000. View at Publisher · View at Google Scholar · View at Scopus
  32. P. Célérier, P. Litoux, and B. Dréno, “In vitro modulation of epidermal inflammatory cytokines (IL-1α, IL-6, TNFα) by minocycline,” Archives of Dermatological Research, vol. 288, no. 7, pp. 411–414, 1996. View at Publisher · View at Google Scholar · View at Scopus
  33. K. Son, S. Fujioka, T. Iida et al., “Doxycycline induces apoptosis in PANC-1 pancreatic cancer cells,” Anticancer Research, vol. 29, no. 10, pp. 3995–4003, 2009. View at Google Scholar · View at Scopus
  34. T. Collins, L. A. Lapierre, W. Fiers, J. L. Strominger, and J. S. Pober, “Recombinant human tumor necrosis factor increases mRNA levels and surface expression of HLA-A,B antigens in vascular endothelial cells and dermal fibroblasts in vitro,” Proceedings of the National Academy of Sciences of the United States of America, vol. 83, no. 2, pp. 446–450, 1986. View at Publisher · View at Google Scholar · View at Scopus
  35. Y. Ikeda-Dantsuji, I. Konomi, and A. Nagayama, “Effects of levofloxacin and doxycycline on interleukin-6 production of Chlamydia trachomatis-infected human synovial fibroblasts,” Chemotherapy, vol. 53, no. 5, pp. 332–337, 2007. View at Publisher · View at Google Scholar · View at Scopus
  36. G. Monfrecola, F. Gaudiello, T. Cirillo, G. Fabbrocini, A. Balato, and S. Lembo, “Nicotinamide downregulates gene expression of interleukin-6, interleukin-10, monocyte chemoattractant protein-1, and tumour necrosis factor-α gene expression in HaCaT keratinocytes after ultraviolet B irradiation,” Clinical & Experimental Dermatology, vol. 38, no. 2, pp. 185–188, 2013. View at Publisher · View at Google Scholar · View at Scopus
  37. P. Neuner, A. Urbanski, F. Trautinger et al., “Increased IL-6 production by monocytes and keratinocytes in patients with psoriasis,” Journal of Investigative Dermatology, vol. 97, no. 1, pp. 27–33, 1991. View at Publisher · View at Google Scholar · View at Scopus
  38. S. Pastore, D. Lulli, A. I. Potapovich et al., “Differential modulation of stress-inflammation responses by plant polyphenols in cultured normal human keratinocytes and immortalized HaCaT cells,” Journal of Dermatological Science, vol. 63, no. 2, pp. 104–114, 2011. View at Publisher · View at Google Scholar · View at Scopus
  39. L. M. Leite, A. G. G. Carvalho, P. L. F. T. Ferreira et al., “Anti-inflammatory properties of Doxycycline and Minocycline in experimental models: an in vivo and in vitro comparative study,” Inflammopharmacology, vol. 19, no. 2, pp. 99–110, 2011. View at Google Scholar · View at Scopus
  40. C. J. Henry, Y. Huang, A. Wynne et al., “Minocycline attenuates lipopolysaccharide (LPS)-induced neuroinflammation, sickness behavior, and anhedonia,” Journal of Neuroinflammation, vol. 5, article 15, 2008. View at Publisher · View at Google Scholar
  41. S. S. V. Padi and S. K. Kulkarni, “Minocycline prevents the development of neuropathic pain, but not acute pain: possible anti-inflammatory and antioxidant mechanisms,” European Journal of Pharmacology, vol. 601, no. 1–3, pp. 79–87, 2008. View at Publisher · View at Google Scholar · View at Scopus
  42. F. Giuliani, W. Hader, and V. W. Yong, “Minocycline attenuates T cell and microglia activity to impair cytokine production in T cell-microglia interaction,” Journal of Leukocyte Biology, vol. 78, no. 1, pp. 135–143, 2005. View at Publisher · View at Google Scholar · View at Scopus
  43. S. V. Aladakatti, P. A. Patil, and V. Vivek, “Influence of tetracyclines on inflammation and their interaction with aspirin in male Wistar rats,” Pharmacology Online, vol. 3, pp. 808–819, 2008. View at Google Scholar